Rafferty Asset Management’s Precigen PGEN Stock Holding History

Rafferty Asset Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.12M	Sell	196,952 -122,260	-38%	-$528K	﹤0.01%	766
2026 Q1	$1.24M	Sell	319,212 -54,990	-15%	-$226K	0.01%	716
2025 Q4	$1.56M	Buy	374,202 +271,478	+264%	+$1.05M	0.01%	703
2025 Q3	$338K	Buy	+102,724	New	+$290K	﹤0.01%	967
2022 Q1	–	Sell	-474,091	Closed	-$1.76M	–	1305
2021 Q4	$1.76M	Buy	474,091 +298,718	+170%	+$1.29M	0.01%	710
2021 Q3	$875K	Sell	175,373 -56,441	-24%	-$325K	0.01%	887
2021 Q2	$1.51M	Sell	231,814 -140,040	-38%	-$979K	0.01%	761
2021 Q1	$2.56M	Buy	371,854 +347,123	+1,404%	+$2.93M	0.02%	564
2020 Q4	$252K	Sell	24,731 -72,556	-75%	-$470K	﹤0.01%	904
2020 Q3	$341K	Buy	+97,287	New	+$462K	﹤0.01%	773
2020 Q2	–	Sell	-13,541	Closed	-$46K	–	990
2020 Q1	$46K	Sell	13,541 -101,480	-88%	-$438K	﹤0.01%	576
2019 Q4	$630K	Sell	115,021 -171,902	-60%	-$968K	0.01%	653
2019 Q3	$1.64M	Buy	286,923 +34,605	+14%	+$235K	0.03%	435
2019 Q2	$1.93M	Sell	252,318 -68,623	-21%	-$369K	0.03%	424
2019 Q1	$1.69M	Buy	+320,941	New	+$2.23M	0.03%	446

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rafferty Asset Management's PGEN Position: Q2 2026 in Review

Rafferty Asset Management reduced its Precigen (PGEN) stake by 38% in Q2 2026, selling an estimated $528K and leaving 196,952 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #766.

Rafferty Asset Management first reported a position in PGEN in Q1 2019 and has held it in 15 quarters since. The position peaked at $2.56M in Q1 2021. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

Rafferty Asset Management held 196,952 shares of Precigen worth $1.12M as of Q2 2026.
Rafferty Asset Management sold 122,260 Precigen shares in Q2 2026, an estimated $528K.
Precigen made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #766 holding.
Rafferty Asset Management first reported a position in Precigen in Q1 2019 and has held it in 15 quarters since.
Rafferty Asset Management's Precigen position peaked at $2.56M in Q1 2021.
211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.